Our people

Latest

Chantal Cabrol

Chantal’s professional background is in advertising and she has extensive experience across the not-for-profit, travel, and advertising industries. She has a Bachelor Degree in Communication Management and an I.A.A. diploma in International Advertising.
Support toddlers like Hayley this EOFY

By making a EOFY tax-deductible donation today, you can help children like Hayley. Funding leading research into this devastating childhood cancer can change survival rates and ensure affected children live a long and healthy life.
Run2Cure Melbourne 2023

Neuroblastoma Australia is delighted to be bringing its signature fundraising event, Run2Cure, to Melbourne! The event will take place on Sunday, November 12 in Melbourne's beautiful Caribbean Gardens.
Running The Great Ocean Road for Neuroblastoma Australia

In May 2023, Dylan Aldous will tackle the half-marathon as part of the Great Ocean Road Running Festival. Running along one of Australia's most beautiful coastlines, Dylan will also be raising funds for Neuroblastoma Australia.

Jake Rose

Jake Rose is a Chartered Accountant and Justice of the Peace with extensive experience in financial operations, as well as business systems and processes.
Nita Arora-Parkes

Nita is founder and Director of Groupcpo; a platform for small businesses and start-ups to find, buy and sell the tools and services they need to grow and scale their business. Nita has over 20 years’ experience as a technology and procurement executive, managing strategic partnerships and vendor negotiations with a global team.
Lucy Jones

Lucy Jones is the CEO of Neuroblastoma and mother to Sienna and Jamie Hoffmann. Lucy is focused on driving change in survival rates through more research, having tragically lost her daughter Sienna to the illness in 2010.
Rochelle Yates

Rochelle is a mother of two, and Chairman of a global logistics company where she specialises in marketing. Rochelle's career includes vast experience in events and promotions and she has brought this skill to help coordinate numerous fundraising events and activities for Neuroblastoma Australia.
Jane Price

Jane Price holds a Bachelor of Arts and a Bachelor of Laws. She is a small business owner, running her own immigration consultancy business, which she has grown in a few short years into a thriving practice with a couple of employees. Jane is lucky enough to have a “pigeon-pair” of children (aged 11 & 14) and was also privileged to know Sienna Hoffman.
Tim Bateman

Director, The Rockpool People and Parlour Capital, Tim Bateman is a father of three and brings a wealth of financial services experience with him. After completing an Economics and Finance Degree, Tim spent 13 years in London working in the derivatives markets. He has worked across stock broking, investment banking, and finance broking in Australasia and the United Kingdom. Among other interests, Tim runs a boutique finance broking firm and was also a franchise owner for Little Kickers, kids’
Dr Louise Causer

Louise is a medical epidemiologist and lecturer currently based at The Kirby Institute, UNSW Australia and has worked internationally both in clinical and research settings across a number of fields. Having trained and working in a highly academic setting for the past decade, Louise has direct experience and key insight into the research setting in Australia and internationally.
Dr Steve DuBois

Dr. DuBois is director of experimental therapeutics at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma. He conducts phase 1 and 2 clinical trials of novel targeted agents. His clinical practice focuses on providing outstanding team-based care for children and young adults with solid cancers.
Associate Professor Juliet Gray

Dr. Juliet Gray is an Associate Professor in Paediatric Oncology at the Cancer Immunology Centre, University of Southampton. She leads a translational research group focused on novel antibody immunotherapies for neuroblastoma, including preclinical evaluation of novel combinational therapies as well as early phase clinical trials.
Sarah White

Sarah is a paediatric Occupational Therapist and is passionate about working with children and families. Sarah brings 20 years experience working in private, not for profit and government health roles specifically in childhood disability and mental health. Since her daughter Isabella was diagnosed with Stage 3 Neuroblastoma in 2011, Sarah has been actively involved in creating awareness and fundraising for Neuroblastoma research.